Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Multi-level Segmentation Solution

    September 6, 2017 | Case study, Quantitative, Segmentation 

    Our client has an established product for multiple indications. They wanted to create a HCP segmentation typing tool which could be implemented in-field to help classify physicians across two different therapeutic areas. There was rationale to suggest that because the two therapeutic areas are pathologically different, then two separate typing tools would be required. However, it was also argued that a one segment solution would be most suitable as physicians fundamentally have the same attitudes, irrespective of the disease they are treating. Additionally, our client would be able to implement a single segmentation tool into its core business much more efficiently than two separate tools. The challenge was to therefore decide whether a one tool or two tool solution would be most suitable.

    Find out more: https://www.researchpartnership.com/news/2017/08/multi-level-segmentation-solution/

    This content was provided by Inizio

    Company Details

    - PMLiVE

    Inizio

    Email
    Website

     Latest Content from  Inizio 

    Atopic Dermatitis — Going Beyond the Pill

    Published in Pharma Exec April 2018 by Mariel Metcalfe

    ESOMAR Asia Pacific 2018

    13-15 May, Bangkok

    Eyeforpharma – Real World Evidence 2018

    16-17 May in Tokyo, Japan

    Intellus Worldwide Summit 2018

    Visit us on stand number 413

    How buyer insights supported the development of an effective market strategy

    Our client was developing a new product for HIV and needed to understand buyer willingness to pay in the emerging markets of South Africa, Kenya, and India. They needed to...

    Conducting market research for scientific publication guide

    Conducting and using market research for publication can be valuable for shaping opinions in healthcare. The findings can be used to influence existing perceptions, change current practices and behaviour in...

    Therapy Watch appoints new Associate Director

    Research Partnership has appointed Mark Hollis to join the Therapy Watch team as Associate Director. Mark has 8 years’ experience in syndicated healthcare, and previously worked in the Market Prognosis team at IQVIA...

    Sabera Hyderally appointed Head of MedTech North America

    Research Partnership is delighted to welcome Sabera Hyderally who has joined the company’s US headquarters in Philadelphia.

    Full speed ahead: Unlock the full potential of your brand tracking

    Wednesday 2nd May 2018 10:30 EST / 15:30 GMT / 16:30 CEST

    How scenario testing helped assess demand for a brand launch in the fragmented NSCLC market

    Our client was developing a new drug aimed at first line NSCLC patients. Ahead of its launch they wanted to assess likely uptake in an already fragmented market space led...